Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy

International Journal of Radiation Oncology, Biology, Physics

Volumn 32, Issue 2, 1995, Pages 465-471

  Wallner, Kent ^a   Roy, Jitendra ^a   Harrison, Louis ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brachytherapy; Dosimetry; Prostatic carcinoma

Indexed keywords

IODINE 125;

ADULT; ARTICLE; BRACHYTHERAPY; DOSE CALCULATION; DOSIMETRY; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RECTUM DISEASE; URETHRA DISEASE; URINE INCONTINENCE;

BRACHYTHERAPY; HUMAN; IODINE RADIOISOTOPES; MALE; MORBIDITY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTUM; SUPPORT, NON-U.S. GOV'T; URETHRA;

EID: 0029008161     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(94)00599-G     Document Type: Article

References (11)

1. Three-dimensional viewing of and dosimetric calculations in Au-198 implants of the prostate
2. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance
3. Anatomic localization of radioactive gold seeds of the prostate by computer-aided tomography
4. Value of computed tomography in interstiti 125-I brachytherapy of prostatic carcinoma
5. Transperineal 125-iodine seed implantation in prostatic cancer guided by transrectal ultrasonography
6. Treatment-related symptoms during the first year following transperineal I-125 prostate implantation
7. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706
8. A CT-based evaluation method for permanent implants: Application to prostate
9. Iodine-125 brachytherapy for early stage prostate cancer: New techniques may achieve better results
10. An improved method for transperineal prostate implants
11. Short-term freedom from disease progression after I-125 prostate implantation